TXG:NASDAQ, 10x Genomics, Inc.

TXG stock overview

10x Genomics, Inc. (TXG:NASDAQ) closed at $69.89 on October 19, 2026, up 0.04% on the day. The stock trades 32.0% below its 52-week high of $102.81 and 488.8% above its 52-week low of $11.87. Over the past year, it gained 431.9%. 10x Genomics, Inc. is part of the Technology sector.

Key figures

Price
$69.89
Day change
+0.04%
Volume
2,526,697
Average volume
3,328,117
Market cap
9B+
52-week range
$11.87 – $102.81
50-day average
$70.90
200-day average
$37.81

Price action over the past year

In 252 trading sessions since October 17, 2025, TXG closed higher on 134 days (53%). Its best day was November 7, 2025 (+17.31%) and its worst was October 6, 2026 (-17.47%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

TXG news

About 10x Genomics, Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others.

Similar stocks

Find more stocks like TXG with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.